Clinical Trial VICCSAR1275


Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Principal Investigator(s)

Vicki Keedy


  • Protocol No. VICCSAR1275
  • Open Date: 03/21/2013
  • Staging: NA
  • Age Group: Both Child and Adult
  • Scope: Local
  • Objective: To use changes in MRI measurements of tumor protein content, cell density, and microvessel perfusion, obtained before and after a single cycle of NAC, to predict eventual tumor response observed at the conclusion of NAC, within patients with osteosarcoma or Ewing Sarcoma
  • Disease Sites: Sarcoma
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01882231
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.